Pulse Biosciences PLSE Stock
Pulse Biosciences Price Chart
Pulse Biosciences PLSE Financial and Trading Overview
| Pulse Biosciences stock price | 25.95 USD |
| Previous Close | 25.6 USD |
| Open | 25.42 USD |
| Bid | 18.6 USD x 200 |
| Ask | 32.7 USD x 200 |
| Day's Range | 25.2 - 26.23 USD |
| 52 Week Range | 12.56 - 28.53 USD |
| Volume | 191.8K USD |
| Avg. Volume | 308.24K USD |
| Market Cap | 1.78B USD |
| Beta (5Y Monthly) | 1.664 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.67 USD |
PLSE Valuation Measures
| Enterprise Value | 1.72B USD |
| Trailing P/E | N/A |
| Forward P/E | -23.587154 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2369.3496 |
| Price/Book (mrq) | 26.450617 |
| Enterprise Value/Revenue | 2287.906 |
| Enterprise Value/EBITDA | -22.489 |
Trading Information
Pulse Biosciences Stock Price History
| Beta (5Y Monthly) | 1.664 |
| 52-Week Change | 65.26% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 28.53 USD |
| 52 Week Low | 12.56 USD |
| 50-Day Moving Average | 23.3 USD |
| 200-Day Moving Average | 18.62 USD |
PLSE Share Statistics
| Avg. Volume (3 month) | 308.24K USD |
| Avg. Daily Volume (10-Days) | 312.55K USD |
| Shares Outstanding | 69.21M |
| Float | 18.34M |
| Short Ratio | 8.2 |
| % Held by Insiders | 73.38% |
| % Held by Institutions | 11.56% |
| Shares Short | 3.09M |
| Short % of Float | 16.05% |
| Short % of Shares Outstanding | 4.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4775.56% |
| Gross Margin | -21.038% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.025% |
| Return on Equity (ttm) | -80.72% |
Income Statement
| Revenue (ttm) | 751K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -158000 USD |
| EBITDA | -76402000 USD |
| Net Income Avi to Common (ttm) | -74567000 USD |
| Diluted EPS (ttm) | -1.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 68.32M USD |
| Total Cash Per Share (mrq) | 0.99 USD |
| Total Debt (mrq) | 7.16M USD |
| Total Debt/Equity (mrq) | 10.79 USD |
| Current Ratio (mrq) | 7.261 |
| Book Value Per Share (mrq) | 0.972 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -55196000 USD |
| Levered Free Cash Flow (ttm) | -29080124 USD |
Profile of Pulse Biosciences
| Country | United States |
| State | FL |
| City | Miami |
| Address | 601 Brickell Key Drive |
| ZIP | 33131 |
| Phone | 510 906 4600 |
| Website | https://www.pulsebiosciences.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 116 |
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Q&A For Pulse Biosciences Stock
What is a current PLSE stock price?
Pulse Biosciences PLSE stock price today per share is 25.95 USD.
How to purchase Pulse Biosciences stock?
You can buy PLSE shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pulse Biosciences?
The stock symbol or ticker of Pulse Biosciences is PLSE.
Which industry does the Pulse Biosciences company belong to?
The Pulse Biosciences industry is Medical Instruments & Supplies.
How many shares does Pulse Biosciences have in circulation?
The max supply of Pulse Biosciences shares is 69.21M.
What is Pulse Biosciences Price to Earnings Ratio (PE Ratio)?
Pulse Biosciences PE Ratio is now.
What was Pulse Biosciences earnings per share over the trailing 12 months (TTM)?
Pulse Biosciences EPS is -1.1 USD over the trailing 12 months.
Which sector does the Pulse Biosciences company belong to?
The Pulse Biosciences sector is Healthcare.
Pulse Biosciences PLSE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}